Genetic stability of Brucella abortus S19 and RB51 vaccine strains by multiple locus variable number tandem repeat analysis (MLVA16)

Vaccine

Volumn 31, Issue 42, 2013, Pages 4856-4859

  Dorneles, Elaine Maria Seles ^a   de Faria, Ana Paula Paiva ^a,b   Pauletti, Rebeca Barbosa ^a   Santana, Jordana Almeida ^a   Caldeira, George Afonso Vítor ^c   Heinemann, Marcos Bryan ^a   Titze de Almeida, Ricardo ^b   Lage, Andrey Pereira ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b UNIVERSITY OF BRASILIA   (Brazil)

^c PECUÁRIA E ABASTECIMENTO   (Brazil)

Author keywords

Brucellosis; Genotyping; MLVA16; Vaccines

Indexed keywords

BRUCELLA ABORTUS RB51 VACCINE; BRUCELLA ABORTUS S19 VACCINE; BRUCELLA VACCINE; LIVE VACCINE; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL GENOME; BACTERIAL STRAIN; BRUCELLA ABORTUS; CONTROLLED STUDY; DRUG DETERMINATION; DRUG QUALITY; GENETIC STABILITY; GENOTYPE; MULTIPLE LOCUS VARIABLE NUMBER OF TANDEM REPEAT ANALYSIS 16; NONHUMAN; PRIORITY JOURNAL; QUALITY CONTROL; VARIABLE NUMBER OF TANDEM REPEAT;

BRUCELLOSIS; GENOTYPING; MLVA16; VACCINES;

BRUCELLA ABORTUS; BRUCELLA VACCINE; DNA FINGERPRINTING; DNA, BACTERIAL; DRUG STABILITY; GENOMIC INSTABILITY; GENOTYPE; MINISATELLITE REPEATS;

EID: 84884209115     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.07.063     Document Type: Article

References (25)

1. OIE Manual of diagnostic tests and vaccines for terrestrial animals 2009, Available from: http://www.oie.int [cited 29.12.11].
2. Corbel M.J., Elberg S.S., Cosivi O. Brucellosis in humans and animals 2006, WHO Press, Geneva.
3. Bérnues A., Manrique E., Maza M.T. Economic evaluation of bovine brucellosis and tuberculosis eradication programmes in a moutain area of Spain. Preventive Veterinary Medicine 1997, 30:137-149.
4. Olsen S.C., Stoffregen W.S. Essential role of vaccines in brucellosis control and eradication programs for livestock. Expert Review of Vaccines 2005, 4:915-928.
5. Bosseray N. Le vaccine 1 Rev.1: dérive des caractères d'immunogénicité et the virulence indépendante des marqueus classiques. Prevention of brucellosis in the Mediterranean countries 1992, 182-186. Pudoc Scientific Wageningen, The Netherlands. M. Plommet (Ed.).
6. Bosseray N. Control methods and thresholds of acceptability for anti-Brucella vaccines. Developments in Biological Standardization 1993, 79:121-128.
7. García-Yoldi D., Le Flèche P., Marín C.M., De Miguel M.J., Munõz P.M., Vernaud G., et al. Assessment of genetic stablility of Brucella melitensis Rev 1 vaccine strain by multiple-locus variable number tandem repeat analysis. Vaccine 2007, 25:2858-2862.
8. Le Flèche P., Jacques I., Grayon M., Al Dahouk S., Bouchon P., Denoeud F., et al. Evaluation and selection of tandem repeat loci for a Brucella MLVA typing assay. BMC Microbiology 2006, 6:9.
9. Al Dahouk S., Le Flèche P., Nöckler K., Jacques I., Grayon M., Scholz H.C., et al. Evaluation of Brucella MLVA typing for human brucellosis. Journal of Microbiological Methods 2007, 69:137-145.
10. Isolamento Tipificação e Genotipagem de Brucella abotus isoladas de bovinos no Brasil 2009, 77. Tese (Doutorado em Ciência Animal) Escola de Veterinária da UFMG.
11. Her M., Kang S.I., Cho D.H., Cho Y.S., Hwang I.Y., Heo Y.R., et al. Application and evaluation of the MLVA typing assay for the Brucella abortus strains isolated in Korea. BMC Microbiology 2009, 9:230.
12. Tiller R.V., De B.K., Boshra M., Huynh L.Y., Van Ert M.N., Wagner D.M., et al. Comparison of two multiple-locus variable-number tandem-repeat analysis methods for molecular strain typing of human Brucella melitensis isolates from the Middle East. Journal of Clinical Microbiology 2009, 47:2226-2231.
13. Álvarez J., Sáez J.L., García N., Serrat C., Pérez-Sancho M., González S., et al. Management of an outbreak of brucellosis due to B. melitensis in dairy cattle in Spain. Research in Veterinary Science 2011, 90:208-211.
14. Scholz H.C., Hubalek Z., Seclácek I., Vergnaud G., Tomaso H., Al Dahouk S., et al. Brucella microti sp. nov., isolated from the commom vole Microtus arvalis. International Journal of Systematic and Evolutionary Microbiology 2008, 58:375-382.
15. Maquart M., Le Flèche P., Foster G., Tryland M., Ramisse F., Djonne B., et al. MLVA-16 typing of 295 marine mammal Brucella isolates from different animal and geographic origins identififies 7 major groups within Brucella ceti and Brucella pinnpedialis. BMC Microbiology 2009, 9:145.
16. Marianelli C., Petrucca A., Pasquali P., Ciuchini F., Papadoulou S., Cipriani P., et al. Use of MLVA-16 typing to trace the source of a laboratory-acquired Brucella infection. Journal of Hospital Infection 2008, 68:274-276.
17. Schulze zur Wiesch J., Wichmann D., Sobottka I., Rohde H., Schmoock G., Wernery R., et al. Genomic tandem repeat analysis proves laboratory-acquired brucellosis in veterinary (camel) diagnostic laboratory in the United Arab Emirates. Zoonoses and Public Health 2010, 57:315-317.
18. Miranda K.L., Poester F.P., Minharro S., Dorneles E.M., Stynen A.P., Lage A.P. Evaluation of Brucella abortus S19 vaccines commercialized in Brazil: Immunogenicity, residual virulence and MLVA15 genotyping. Vaccine 2013, 31:3014-3018.
19. Brasil, 2004. Instrução Normativa no. 15, de 19 de fevereiro de 2004. Regulamento técnico para produção e controle de qualidade da vacina contra a brucelose e antígenos para diagnóstico da brucelose 2004, Diário Oficial da União, Brasília, DF.
20. Pitcher D.G., Saunders N.A., Owern R.J. Rapid extraction of bacterial genomic DNA with guanidium thyocianate. Letters in Applied Microbiology 1989, 8:151-156.
21. Sambrook J., Russel D. Molecular cloning: a laboratory manual 2001, CSHL Press, Plymouth. 3rd ed.
22. Milward F.W. Production and quality control of vaccines for brucellosis and a specific emphasis on Rev.1 vaccine 1995, FAO/WHO/OIE Round table on the use of Rev. 1 vaccine in small ruminants and cattle CNEVA Alfort, France.
23. Bricker B.J., Ewalt D.R., Halling S.M. Brucella 'HOOF-Prints': strain typing by multi-locus analysis of variable number tandem repeats (VNTRs). BMC Microbiology 2003, 3:15.
24. Brasil, 2007. Ministério da Agricultura, Pecuária e Abastecimento. Instrução Normativa n° 33, de 24 de agosto de 2007. Estabelece condições para vacinação de fêmeas bovinas contra brucelose, utilizando vacina não indutora da formação de anticorpos aglutinantes, amostra RB51 2007, Diário Oficial da União, Brasília, DF.
25. Whatmore A.M., Shankster S.J., Perrett L.L., Murphy P.T., Brew S.D., Thirlwall R.E., et al. Identification and characterization of variable-number tandem-repeat markers for typing of Brucella spp. Journal of Clinical Microbiology 2006, 44:1982-1993.